Sinovac Biotech Ltd (SVA)
6.47
0.00 (0.00%)
USD |
NASDAQ |
Nov 13, 16:00
Sinovac Biotech Enterprise Value: -6.942B for Nov. 13, 2024
Enterprise Value Chart
Historical Enterprise Value Data
Date | Value |
---|---|
November 13, 2024 | -6.942B |
November 12, 2024 | -6.942B |
November 11, 2024 | -6.942B |
November 08, 2024 | -6.942B |
November 07, 2024 | -6.942B |
November 06, 2024 | -6.942B |
November 05, 2024 | -6.942B |
November 04, 2024 | -6.942B |
November 01, 2024 | -6.942B |
October 31, 2024 | -6.942B |
October 30, 2024 | -6.942B |
October 29, 2024 | -6.942B |
October 28, 2024 | -6.942B |
October 25, 2024 | -6.942B |
October 24, 2024 | -6.942B |
October 23, 2024 | -6.942B |
October 22, 2024 | -6.942B |
October 21, 2024 | -6.942B |
October 18, 2024 | -6.942B |
October 17, 2024 | -6.942B |
October 16, 2024 | -6.942B |
October 15, 2024 | -6.942B |
October 14, 2024 | -6.942B |
October 11, 2024 | -6.942B |
October 10, 2024 | -6.942B |
Date | Value |
---|---|
October 09, 2024 | -6.942B |
October 08, 2024 | -6.942B |
October 07, 2024 | -6.942B |
October 04, 2024 | -6.942B |
October 03, 2024 | -6.942B |
October 02, 2024 | -6.942B |
October 01, 2024 | -6.942B |
September 30, 2024 | -6.942B |
September 27, 2024 | -6.942B |
September 26, 2024 | -6.942B |
September 25, 2024 | -6.942B |
September 24, 2024 | -6.942B |
September 23, 2024 | -6.942B |
September 20, 2024 | -6.942B |
September 19, 2024 | -6.942B |
September 18, 2024 | -6.942B |
September 17, 2024 | -6.942B |
September 16, 2024 | -6.942B |
September 13, 2024 | -6.942B |
September 12, 2024 | -6.942B |
September 11, 2024 | -6.942B |
September 10, 2024 | -6.942B |
September 09, 2024 | -6.942B |
September 06, 2024 | -6.942B |
September 05, 2024 | -6.942B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-7.191B
Minimum
Jun 26 2024
-6.942B
Maximum
Jul 01 2024
-6.950B
Average
-6.942B
Median
Jul 01 2024
Enterprise Value Benchmarks
CASI Pharmaceuticals Inc | 91.55M |
Zai Lab Ltd | 2.423B |
China SXT Pharmaceuticals Inc | -8.059M |
Adagene Inc | 29.78M |
LakeShore Biopharma Co Ltd | -- |
Enterprise Value Related Metrics
Earnings Yield | -20.25% |
Normalized Earnings Yield | -10.50 |